A. A. DUNK
Impact in
- Hepatology top 5%
- Liver Disease and Transplantation
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
-
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in ⓘ
-
- Liver Disease and Transplantation 4
- Hepatocellular Carcinoma Treatment and Prognosis 2
- Hepatitis C virus research 2
-
- Liver Disease Diagnosis and Treatment 4
- Hepatitis B Virus Studies 2
- Co-authors
- Howard C. Thomas (6 shared papers)R P Walt (3 shared papers)Sheila Sherlock (3 shared papers)W. J. Jenkins (2 shared papers)Tadashi Ikeda (1 shared paper)Massimo Pignatelli (1 shared paper)N. A. G. Mowat (4 shared papers)P W Brunt (2 shared papers)
- Journals
- Alimentary Pharmacology & Therapeutics (5 papers)Journal of Hepatology (4 papers)QJM (1 paper)British Journal of Clinical Pharmacology (1 paper)Gut (1 paper)
- Partner nations
- United KingdomTaiwanIreland
In The Last Decade
A. A. DUNK
18 papers receiving 310 citations
Peers
Comparison fields: 5 of 63
- Hepatology 209
- Epidemiology 167
- Pharmacology 20
- Oncology 52
- Psychiatry and Mental health 26
Countries citing papers authored by A. A. DUNK
This map shows the geographic impact of A. A. DUNK's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. A. DUNK with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. A. DUNK more than expected).
Fields of papers citing papers by A. A. DUNK
This network shows the impact of papers produced by A. A. DUNK. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. A. DUNK. The network helps show where A. A. DUNK may publish in the future.
Co-authors
The 25 scholars most cited alongside A. A. DUNK, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 57 | |
| 2 | 1986 | 50 | |
| 3 | 1986 | 44 | |
| 4 | 1983 | 36 | |
| 5 | 1985 | 27 | |
| 6 | 1983 | 18 | |
| 7 | 1982 | 18 | |
| 8 | 1987 | 17 | |
| 9 | 1998 | 14 | |
| 10 | 1990 | 10 | |
| 11 | 1982 | 10 | |
| 12 | 1988 | 9 | |
| 13 | 1990 | 8 | |
| 14 | 1987 | 6 | |
| 15 | 1987 | 4 | |
| 16 | 1980 | 4 | |
| 17 | Mitoxantrone as single agent therapy in primary hepatocellular carcinoma | 1984 | 3 |
| 18 | 1988 | 3 |
About A. A. DUNK
A. A. DUNK is a scholar working on Hepatology, Epidemiology, Molecular Biology, Oncology and Surgery, having authored 18 papers that have together received 338 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (4 papers), Liver Disease and Transplantation (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Cancer Treatment and Pharmacology (2 papers), Hepatitis B Virus Studies (2 papers), Hepatitis C virus research (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Chemotherapy-induced cardiotoxicity and mitigation (2 papers). The work is most often cited by research in Hepatology (209 citations), Epidemiology (167 citations), Pharmacology (20 citations), Oncology (52 citations) and Psychiatry and Mental health (26 citations). A. A. DUNK has collaborated with scholars based in United Kingdom, Taiwan and Ireland. Frequent co-authors include Howard C. Thomas, R P Walt, Sheila Sherlock, W. J. Jenkins, Tadashi Ikeda, Massimo Pignatelli, N. A. G. Mowat, P W Brunt, T S Sinclair and Anna S. Lok. Their work appears in journals such as Alimentary Pharmacology & Therapeutics, Journal of Hepatology, QJM, British Journal of Clinical Pharmacology and Gut.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.